Fred Hutch Cancer Center — Seattle, Washington

Fred Hutch Cancer Center is a clinical research site located in Seattle, Washington, United States 98109.

Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

Fred Hutch Cancer Center has participated in 11 clinical trials with 10 currently active.

Therapeutic areas: Multiple Myeloma, Colon Cancer, Metastatic Colon Cancer.

Sponsors: Karyopharm Therapeutics Inc, Sapience Therapeutics, A2 Biotherapeutics Inc..

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Fred Hutch Cancer Center?

Fred Hutch Cancer Center has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Fred Hutch Cancer Center conducted?

Fred Hutch Cancer Center has 11 clinical trials on record, with 10 currently active. Their work covers Multiple Myeloma, Colon Cancer, Metastatic Colon Cancer.

Is Fred Hutch Cancer Center accredited by Crixeo Health?

Yes — Fred Hutch Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Fred Hutch Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.